WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007084487) PERICYTES FOR USE AS STEM CELLS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2007/084487 International Application No.: PCT/US2007/001107
Publication Date: 26.07.2007 International Filing Date: 16.01.2007
IPC:
C12N 5/074 (2010.01) ,C12N 5/0775 (2010.01)
Applicants: DORE-DUFFY, Paula[US/US]; US (UsOnly)
KATYCHEV, Andre[US/US]; US (UsOnly)
WANG, Xueqian[US/US]; US (UsOnly)
WAYNE STATE UNIVERSITY[US/US]; 4249 Fab, 656 West Kirby Detroit, MI 48202, US (AllExceptUS)
Inventors: DORE-DUFFY, Paula; US
KATYCHEV, Andre; US
WANG, Xueqian; US
Agent: RINALDO, Amy, E.; KOHN & ASSOCIATES, PLLC 30500 Northwestern Highway, Suite 410 Farmington Hills, MI 48334, US
Priority Data:
60/759,25813.01.2006US
Title (EN) PERICYTES FOR USE AS STEM CELLS
(FR) PÉRICYTES UTILISÉS COMME CELLULES SOUCHES
Abstract: front page image
(EN) A method of promoting perictye differentiation by selectively culturing pericytes in an enriched environment containing a promoter specific to a type of differentiation. Isolated and purified multipotent pericytes or pericyte precursors are provided. A stem cell therapy replacement comprising isolated and purified multipotent pericytes. A treatment of disease comprising an effective amount of isolated and purified multipotent pericytes or pericyte precursors is provided.
(FR) L'invention concerne un procédé pour promouvoir la différenciation des péricytes par culture sélective de péricytes dans un environnement enrichi contenant un promoteur spécifique à un type de différenciation. Cette invention concerne également des péricytes multipotents purifiés et isolés ou des précurseurs de ces péricytes, un substitut à la thérapie par cellules souches contenant des péricytes multipotents purifiés et isolés ainsi qu'un traitement contre une maladie, qui contient une quantité efficace de péricytes multipotents purifiés et isolés ou des précurseurs de ces péricytes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)